Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 10829 

FOR FURTHER INFORMATION CONTACT: 

Suzanne H. Plimpton, Reports Clearance 

Officer, National Science Foundation, 

2415 Eisenhower Avenue, Alexandria, 

VA 22314, 703–292–7556, or send email 

to splimpto@nsf.gov. Individuals who 

use a telecommunications device for the 

deaf (TDD) may call the Federal 

Information Relay Service (FIRS) at 1– 

800–877–8339, which is accessible 24 

hours a day, 7 days a week, 365 days a 

year (including federal holidays). 

Comments regarding this information 

collection are best assured of having 

their full effect if received within 30 

days of this notification. Copies of the 

submission(s) may be obtained by 

calling 703–292–7556. 

NSF may not conduct or sponsor a 

collection of information unless the 

collection of information displays a 

currently valid OMB control number, 

and the agency informs potential 

persons who are to respond to the 

collection of information that such 

persons are not required to respond to 

the collection of information unless it 

displays a currently valid OMB control 

number. 

SUPPLEMENTARY INFORMATION: 

Title of Collection: Notification 

Requirements Regarding Sexual 

Harassment, Other Forms of 

Harassment, or Sexual Assault. 

OMB Number: 3145–0249. 

Type of Request: Renewal with 

change of an information collection. 

Proposed Project: The primary 

purpose of this data collection is for 

institutional authorized organizational 

representatives to inform NSF of any 

finding/determination regarding the 

Principal Investigator (PI) or any co-PI 

that demonstrates a violation of awardee 

policies or codes of conduct, statutes, 

regulations, or executive orders relating 

to sexual harassment, other forms of 

harassment, or sexual assault; and/or if 

the PI or any co-PI is placed on 

administrative leave or if any 

administrative action has been imposed 

on the PI or any co-PI by the awardee 

relating to any finding/determination or 

an investigation of an alleged violation 

of awardee policies or codes of conduct, 

statutes, regulations, or executive orders 

relating to sexual harassment, other 

forms of harassment, or sexual assault. 

The awardee is required to notify NSF 

of: (1) Any finding/determination 

regarding the PI or any co-PI that 

demonstrates a violation of awardee 

policies or codes of conduct, statutes, 

regulations, or executive orders relating 

to sexual harassment, other forms of 

harassment, or sexual assault; and/or (2) 

if the PI or any co-PI is placed on 

administrative leave or if any 

administrative action has been imposed 

on the PI or any co-PI by the awardee 

relating to any finding/determination or 

an investigation of an alleged violation 

of awardee policies or codes of conduct, 

statutes, regulations, or executive orders 

relating to sexual harassment, other 

forms of harassment, or sexual assault. 

Such notification must be submitted by 

the Authorized Organizational 

Representative (AOR) or designee to 

NSF’s Office of Equity and Civil Rights 

at: https://www.nsf.gov/OD/OECR/ 

notification_form.jsp within ten 

business days from the date of the 

finding/determination, or the date of the 

placement of a PI or co-PI by the 

awardee on administrative leave or the 

imposition of an administrative action, 

whichever is sooner. Each notification 

must include the following information: 

• NSF Award Number; 

• Name of PI or co-PI being reported; 

• Type of Notification: Select one of 

the following: 

—Finding/Determination that the 

reported individual has been found to 

have violated awardee policies or 

codes of conduct, statutes, 

regulations, or executive orders 

relating to sexual harassment, other 

forms of harassment, or sexual 

assault; or 

—Placement by the awardee of the 

reported individual on administrative 

leave or the imposition of any 

administrative action on the PI or any 

co-PI by the awardee relating to any 

finding/determination or an 

investigation of an alleged violation of 

awardee policies or codes of conduct, 

statutes, regulations, or executive 

orders relating to sexual harassment, 

other forms of harassment, or sexual 

assault. 

• Description of the finding/ 

determination and action(s) taken, if 

any; and 

• Reason(s) for, and conditions of, 

placement of the PI or any co-PI on 

administrative leave or imposition of 

administrative action. 

Use of the Information: NSF will use 

the information in consultation with the 

awardee to determine whether the NSF 

award activities can be carried out as 

proposed and in a manner that protects 

the safety and security of award 

personnel. 

Burden on the Public: It has been 

estimated that respondents will expend 

an average of one hour to complete the 

form. 

Comments: Comments are invited on 

(a) whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

Agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the Agency’s 

estimate of the burden of the proposed 

collection of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information on respondents, 

including through the use of automated 

collection techniques or other forms of 

information technology; and (d) ways to 

minimize the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Dated: February 22, 2022. 

Suzanne H. Plimpton, 

Reports Clearance Officer, National Science 

Foundation. 

[FR Doc. 2022–03975 Filed 2–24–22; 8:45 am] 

BILLING CODE 7555–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2015–0063] 

Reassessment of NRC’s Dollar per 

Person-Rem Conversion Factor Policy 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: NUREG; issuance. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is issuing NUREG– 

1530, Revision 1, ‘‘Reassessment of 

NRC’s Dollar Per Person-Rem 

Conversion Factor Policy.’’ This 

revision to NUREG–1530 updates the 

dollar per person-rem conversion factor 

and establishes a method for keeping 

this factor up-to-date. The NRC uses the 

dollar per person-rem conversion factor 

in cost-benefit analyses to determine the 

monetary valuation of the consequences 

associated with radiological exposure 

and establishes this factor by 

multiplying a value of a statistical life 

(VSL) coefficient by a cancer mortality 

risk coefficient. 

DATES: NUREG–1530, Revison 1 is 

available on February 25, 2022. 

ADDRESSES: Please refer to Docket ID 

NRC–2015–0063 when contacting the 

NRC about the availability if 

information regarding this document. 

You may obtain publicly available 

information related to this document 

using any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2015–0063. Address 

questions about Docket IDs to Stacy 

Schumann; telephone: 301–415–0624; 

email: Stacy.Schumann@nrc.gov. For 

technical questions, contact the 


lotter on DSK11XQN23PROD with NOTICES1
10830 Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 

individual listed in the FOR FURTHER

INFORMATION CONTACT section of this 

document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to 

PDR.Resource@nrc.gov. The ADAMS 

accession number for each document 

referenced (if it is available in ADAMS) 

is provided the first time that it is 

mentioned in this document. 

• NRC’s PDR: You may examine and 

purchase copies of public documents, 

by appointment, at the NRC’s PDR, 

Room P1 B35, One White Flint North, 

11555 Rockville Pike, Rockville, 

Maryland 20852. To make an 

appointment to visit the PDR, please 

send an email to PDR.Resource@nrc.gov 

or call 1–800–397–4209 or 301–415– 

4737, between 8:00 a.m. and 4:00 p.m. 

(ET), Monday through Friday, except 

Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

Pamela Noto, Office of Nuclear Material 

Safety and Safeguards, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001; telephone: 301–415– 

6795, email: Pamela.Noto@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Discussion 

Revision 1 to NUREG–1530 (ADAMS 

Accession No. ML22053A025) updates 

the dollar per person-rem conversion 

factor and establishes a method for 

keeping this factor up-to-date. The NRC 

applies the dollar per person-rem 

conversion factor from NUREG–1530 in 

a variety of regulatory applications that 

require the determination of the 

monetary valuation of the consequences 

associated with radiological exposure. 

This factor is established by multiplying 

a VSL coefficient by a nominal risk 

coefficient. 

In 2009, the NRC staff initiated 

research on the bases for the 

determination of the VSL and performed 

outreach with other Federal agencies on 

their values and use. The VSL is not a 

value placed on human life, but a value 

that society would be willing to pay for 

reducing health risk. The concept of a 

VSL is used throughout the Federal 

government to monetize the health 

benefits of a safety regulation. 

Subsequently in 2011 the magnitude of 

the societal effects of the accident at the 

Fukushima Dai-ichi nuclear power plant 

in Japan led the NRC to evaluate how its 

regulatory framework considers offsite 

property damage and the associated 

economic consequences that could be 

caused by a significant radiological 

release from an NRC-licensed facility. 

Following this evaluation, the NRC 

staff requested Commission approval in 

SECY–12–0110, ‘‘Consideration of 

Economic Consequences within the U.S. 

Nuclear Regulatory Commission’s 

Regulatory Framework,’’ dated August 

14, 2012 (ADAMS Package Accession 

No. ML12173A478) to continue work on 

updating the 1995 dollar per person-rem 

conversion factor in NUREG–1530 

(ADAMS Accession No. ML063470485). 

The 1995 dollar per person-rem value 

was set at $2,000. This number resulted 

from the multiplication of a VSL of $3 

million by a risk coefficient for 

stochastic health effects of 7.3 × 10¥4

per person-rem. In the March 20, 2013 

staff requirements memorandum 

associated with SECY–12–0110 

(ADAMS Accession No. ML13079A055), 

the Commission approved the staff’s 

request to continue the activities 

associated with the update to the dollar 

per person-rem conversion factor policy. 

This revision to NUREG–1530 makes 

five main changes. First, the revision to 

NUREG–1530 updates the dollar per 

person-rem conversion factor to $5,200 

per person-rem. The value is based on 

the application of an updated best 

estimate VSL of $9.0 million and the 

U.S. Environmental Protection Agency’s 

(EPA) cancer mortality risk coefficient 

factor of 5.8 × 10¥4 per person-rem. The 

VSL estimate is derived from the 

average of both the U.S. Department of 

Transportation’s and the EPA’s VSL in 

2014 dollars. 

Second, the NUREG adopts low and 

high dollar per person-rem conversion 

factor estimates for use in sensitivity 

analyses. The NRC staff recommends 

varying the dollar per person-rem 

conversion factor by plus or minus 50 

percent. This results in a range of 

conversion factors with a low value of 

$2,600 per person-rem and a high value 

of $7,800 per person-rem. 

Third, this revision to NUREG–1530 

indicates that the NRC staff will round 

to two significant figures instead of 

rounding to the nearest thousand dollar 

value. Historically, the NRC has 

rounded this number to the nearest 

thousand dollars for the purposes of 

dollar per person-rem estimates. Given 

the large uncertainties inherent in this 

approach, updates would have little to 

no impact on this value between 

periodic baseline reviews. 

Fourth, this revision establishes a 

methodology for keeping the dollar per 

person-rem conversion factor up-todate. An example of the NRC’s 

methodology to update the dollar per 

person-rem conversion factor is 

provided in the NUREG. The NUREG 

also provides procedures for rebaselining the dollar per person-rem 

conversion factor. 

Finally, this revision provides 

guidance to the NRC staff on when to 

use a higher dollar per person-rem 

factor in rare accident sequences with 

high dose or dose rates for a portion of 

the population. 

II. Public Outreach 

The NRC staff held a Category 3 

public meeting on April 2, 2015, to 

discuss the update to NUREG–1530. The 

NRC presentation can be found in 

ADAMS under Accession No. 

ML15086A112, and the meeting 

summary under Accession No. 

ML15098A649. In response to this 

meeting, the Nuclear Energy Institute 

submitted a letter to the NRC, which 

provided feedback on the proposed 

update. This letter and the associated 

attachment can be found in ADAMS 

under Accession Nos. ML15126A489 

and ML15126A498, respectively. The 

NRC staff published the draft NUREG– 

1530, Revision 1 in the Federal Register 

(80 FR 53585, September 4, 2015) for a 

60-day public comment period. The 

staff received 11 comment submissions 

with a total of 38 individual comments 

from industry and members of the 

public. The NRC responses to these 

public comments can be found in 

ADAMS under Accession No. 

ML16147A501. External participants 

also expressed views on the update to 

NUREG–1530 during the July 26, 2016, 

Commission meeting with NRC 

stakeholders. Additionally, the NRC 

staff briefed the Advisory Committee on 

Reactor Safeguards (ACRS) Regulatory 

Policies and Practices Subcommittee on 

February 7, 2017, and the ACRS Full 

Committee on March 9, 2017. 

III. Backfitting, Forward Fitting, and 

Issue Finality 

The NRC’s issuance and use of this 

report do not constitute backfitting as 

that term is defined in Section 50.109 of 

title 10 of the Code of Federal 

Regulations (10 CFR), ‘‘Backfitting,’’ and 

as described in NRC Management 

Directive (MD) 8.4, ‘‘Management of 

Backfitting, Forward Fitting, Issue 

Finality, and Information Requests’’; do 

not affect the issue finality of an 

approval under 10 CFR part 52, 

‘‘Licenses, Certifications, and Approvals 

for Nuclear Power Plants’’ and do not 

constitute forward fitting as that term is 

defined and described in MD 8.4. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 10831 

IV. Congressional Review Act 

This NUREG is a rule as defined in 

the Congressional Review Act (5 U.S.C. 

801–808). However, the Office of 

Management and Budget has not found 

it to be a major rule as defined in the 

Congressional Review Act. 

Dated: February 22, 2022. 

For the Nuclear Regulatory Commission. 

John R. Tappert, 

Director, Division of Rulemaking, 

Environmental, and Financial Support, Office 

of Nuclear Material Safety and Safeguards. 

[FR Doc. 2022–04058 Filed 2–24–22; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2021–0194] 

Guidance for Implementation of 10 

CFR 50.59, ‘‘Changes, Tests and 

Experiments,’’ at Non-Power 

Production or Utilization Facilities 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Regulatory guide; issuance. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is issuing a new 

Regulatory Guide (RG) 2.8 (Revision 0), 

Guidance for Implementation of 10 CFR 

50.59, ‘‘Changes, Tests and 

Experiments,’’ at Non-Power Production 

or Utilization Facilities. This RG 

describes an approach that is acceptable 

to the NRC staff to meet the regulatory 

requirements, ‘‘Changes, tests and 

experiments,’’ at a non-power 

production and utilization facility, as 

defined in RG 2.8. 

DATES: Revision 0 to RG 2.8 is available 

on February 25, 2022. 

ADDRESSES: Please refer to Docket ID 

NRC–2021–0194 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly available 

information related to this document 

using any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0194. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions, contact the individuals listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to 

PDR.Resource@nrc.gov. The ADAMS 

accession number for each document 

referenced (if it is available in ADAMS) 

is provided the first time that it is 

mentioned in this document. 

• NRC’s PDR: You may examine and 

purchase copies of public documents, 

by appointment, at the NRC’s Public 

Document Room (PDR), Room P1 B35, 

One White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. To 

make an appointment to visit the PDR, 

please send an email to PDR.Resource@

nrc.gov or call 1–800–397–4209 or 301– 

415–4737, between 8:00 a.m. and 4:00 

p.m. (ET), Monday through Friday, 

except Federal holidays. 

Revision 0 to RG 2.8 and the 

regulatory analysis may be found in 

ADAMS under Accession Nos. 

ML22020A292 and ML21243A104, 

respectively. 

Regulatory guides are not 

copyrighted, and NRC approval is not 

required to reproduce them. 

FOR FURTHER INFORMATION CONTACT: 

Michael Eudy, Office of Nuclear 

Regulatory Research, telephone: 301– 

415–3104, email: Michael.Eudy@nrc.gov 

and Duane Hardesty, Office of Nuclear 

Reactor Regulation, telephone: 301– 

415–3724, email: Duane.Hardesty@

nrc.gov. Both are staff members of the 

U.S. Nuclear Regulatory Commission, 

Washington, DC 20555–0001. 

SUPPLEMENTARY INFORMATION: 

I. Discussion 

The NRC is issuing a new guide in the 

NRC’s ‘‘Regulatory Guide’’ series. This 

series was developed to describe and 

make available to the public information 

regarding methods that are acceptable to 

the NRC staff for implementing specific 

parts of the agency’s regulations, 

techniques that the NRC staff uses in 

evaluating specific issues or postulated 

events, and data that the NRC staff 

needs in its review of applications for 

permits and licenses. 

RG 2.8 was issued with a temporary 

identification of Draft Regulatory Guide, 

DG–DG–2007 (ADAMS Accession No. 

ML21243A103). 

II. Additional Information 

The NRC published a notice of the 

availability of DG–2007 in the Federal 

Register on November 23, 2021 (86 FR 

66464) for a 30-day public comment 

period. The public comment period 

closed on December 23, 2021. Public 

comments on DG–2007 and the staff 

responses to the public comments are 

available under ADAMS under 

Accession No. ML22020A296. 

III. Congressional Review Act 

This RG is a rule as defined in the 

Congressional Review Act (5 U.S.C. 

801–808). However, the Office of 

Management and Budget has not found 

it to be a major rule as defined in the 

Congressional Review Act. 

IV. Backfitting, Forward Fitting, and 

Issue Finality 

The NRC staff may use this RG as a 

reference in its regulatory processes, 

such as licensing, inspection, or 

enforcement. However, the NRC staff 

does not intend to use the guidance in 

this RG to support NRC staff actions in 

a manner that would constitute 

backfitting as that term is defined in 

Section 50.109 of title 10 of the Code of 

Federal Regulations (10 CFR), 

‘‘Backfitting,’’ and as described in NRC 

Management Directive (MD) 8.4, 

‘‘Management of Backfitting, Forward 

Fitting, Issue Finality, and Information 

Requests.’’ However, the backfitting 

provisions in 10 CFR 50.109, do not 

apply to Part 50 licensees other than 

power reactors. The regulatory basis for 

10 CFR 50.109 was expressed solely in 

terms of nuclear power reactors. The 

NRC’s Advanced Notice of Proposed 

Rulemaking, Policy Statement, Proposed 

Rules, and Final Rules for amendments 

to 10 CFR 50.109 in the 1980s involved 

only nuclear power reactors. As a result, 

the NRC has not applied 10 CFR 50.109 

to research reactors, testing facilities, 

and other non-power facilities licensed 

under 10 CFR part 50 (e.g., ‘‘Final Rule; 

Clarification of Physical Protection 

Requirements at Fixed Sites’’). In a 2012 

final rule concerning non-power 

reactors, the NRC stated, ‘‘The NRC has 

determined that the backfit provisions 

in 10 CFR 50.109 do not apply to test, 

research, or training reactors because 

the rulemaking record for 10 CFR 50.109 

indicates that the Commission intended 

to apply this provision to only power 

reactors, and NRC practice has been 

consistent with this rulemaking record’’ 

(‘‘Final Rule; Requirements for 

Fingerprint-Based Criminal History 

Records Checks for Individuals Seeking 

Unescorted Access to Non-Power 

Reactors’’). 

V. Submitting Suggestions for 

Improvement of Regulatory Guides 

A member of the public may, at any 

time, submit suggestions to the NRC for 

improvement of existing RGs or for the 

development of new RGs. Suggestions 

can be submitted on the NRC’s public 


lotter on DSK11XQN23PROD with NOTICES1